1,428 results on '"Mimori, Koshi"'
Search Results
102. Supplementary Figure S2 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
103. Supplementary Figure 1 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
104. Supplementary Figure 4 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
105. Supplementary Table S1 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
106. Supplementary Figure 1 from Fhit Modulates the DNA Damage Checkpoint Response
107. Supplementary Figure 3 from Fhit Modulates the DNA Damage Checkpoint Response
108. Supplementary Figure 2 from Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
109. Data from Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
110. Supplementary Table 1 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
111. Supplementary Materials and Methods, Legends for Supplementary Figures from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
112. Data from Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
113. Supplementary Figure 3 from Fhit-Deficient Hematopoietic Stem Cells Survive Hydroquinone Exposure Carrying Precancerous Changes
114. Supplementary Figure 2 from Fhit-Deficient Hematopoietic Stem Cells Survive Hydroquinone Exposure Carrying Precancerous Changes
115. Supplementary Figure 7 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
116. Supplementary Figure 3 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
117. Data from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
118. Supplementary Figure 2 from Fhit Modulates the DNA Damage Checkpoint Response
119. Supplementary Figures S1-S9 from Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
120. Supplementary Tables S1-S2 from Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
121. Supplementary Tables 2A-B from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
122. Supplementary Table 3 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
123. Supplementary Figure 5 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
124. Supplementary Figure 6 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
125. Supplementary Figure Legends from Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
126. Supplementary Figure 3 from Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
127. Supplementary Figure Legends 1-7 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
128. Supplementary Figure 2 from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
129. Data from p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
130. Data from Fhit-Deficient Hematopoietic Stem Cells Survive Hydroquinone Exposure Carrying Precancerous Changes
131. Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
132. Novel and classic approaches for managing gastrointestinal cancers
133. Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases
134. Disclosing quantitative RT‐PCR raw data during manuscript submission: a call for action
135. Extraction of cell-free DNA from urine, using polylysine-coated silica particles
136. Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer
137. Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma
138. Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma
139. As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma
140. Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer
141. Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma
142. Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer
143. PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer
144. Esophageal lymphangioma: Endoscopic ultrasound, computed tomography, and magnetic resonance imaging appearance
145. Cancer Stem Cells: Gastrointestinal Cancers
146. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial–mesenchymal transition
147. The comprehensive review of gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) from diagnosis and treatment.
148. Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations.
149. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer
150. Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.